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Background: Vertical right axillary mini-thoracotomy (VRAMT) represents a minimal-
invasive and cosmetically attractive alternative for selected congenital heart defects. We 
report our institutional experience with VRAMT, especially regarding the performance of 
percutaneous femoral venous access to establish extracorporeal circulation in this pediatric 
population. 
 
Methods: Retrospective single center analysis of children up to 16 years who underwent 
corrective cardiac surgery using VRAMT over a period of 5 years. VRAMT involved a 4-5 cm 
vertical incision parallel to the anterior axillary fold and aortic/bicaval cannulation. Since 
2016, the technique has been modified and the inferior-vena-cava was cannulated using 
femoral percutaneous-venous-access. The primary endpoints were all-cause mortality with 
additional secondary endpoints of major adverse cardiac and cerebrovascular events 
(MACCE) and conversion to median sternotomy.  
 
Results: A total of 110 patients with biventricular congenital malformations were included. 
Age was 2.3 (0.2-16) years and body weight was 11 (3-47) kg. Extracorporeal-circulation-
time was 66 (24-167) minutes, cross clamp time was 41 (9-95) minutes. Fast-track-
management with on-table extubation was achieved in 34.5% (n=38). For patients with 
percutaneous-femoral venous-cannulation (n=38, 34.5%), thrombosis at the cannulation site 
was recorded in 5 (13.5%) cases. There was no early or late mortality during the follow-up of 
14.4 (0.8 – 47.19) months. No wound infection nor thoracic deformities were observed.  
 
Conclusions: VRAMT can be considered as an alternative, minimal-invasive and 
cosmetically attractive access for the repair of frequent congenital heart defects in newborns 
and young children. Percutaneous-femoral-venous cannulation provides sufficient ECC flow 











ASD - atrial septal defect 
BH – beating heart 
BMI - body mass index 
BSA – body surface area 
CAVSD - complete atrioventricular septal defects  
CL - cardioplegia line 
DCRV – double chambered right ventricle 
ECC – extracorporeal circulation circuit 
FR – french scale system 
IVC – inferior vena cava 
MACCE - major adverse cardiac and cerebrovascular events 
MI - myocardial infarction 
MS – median sternotomy 
PAVSD - partial atrioventricular septal defects F 
PAPVC - partial anomalous pulmonary venous connection 
PFO - persistent foramen ovale 
PLSVC - persistent left superior vena cava,  
MS - median sternotomy 
REDCap - research electronic data capture 
SVC - superior vena cava 
TEE - transoesophageal-echocardiography 
VRAMT - vertical-right-axillary-mini-thoracotomy  











After the first successful intracardiac correction of an atrio-septal defect by Lewis and Varco 
in 1952, surgical methods have become safer and with increasing technological possibilities, 
the urge for minimal invasive operations has reached the domain of cardiac surgery [1,2].  
 
Median sternotomy has been the gold standard to perform open cardiac surgery for the 
repair of congenital heart defects in the past. This access is considered as rather invasive, it 
results in a well visible scar on the midline of the chest. Especially in growing children, the 
resulting stigma of being a “heart patient” can lead to long lasting psychological distress [3-
5].  
 
Several different accesses to the heart have been assessed such as partial sternotomy [6,7], 
anterolateral thoracotomy [8,9], and posterior thoracotomy [10,11]. As for the anterolateral 
thoracotomy however, an impairment of breast development especially when performed in 
pre-pubescent females has been noticed and this access has therefore been considered 
suboptimal for these particular patients [12].  
 
In order to perform surgery without increased risk and to achieve a satisfactory surgical 
outcome, site and length of the incision must allow sufficient access to the surgical field., 
Ideally, central arterial cannulation should be performed in order to avoid potential vascular 
complications observed following femoral artery cannulation especially in smaller infants. As 
described before, a right axillary incision exposes sufficiently the right atrium and right heart 
structures as needed for the repair of some of the congenital heart defects [3,13].  
 
The reporting institution started to perform closure of atrial septal defects by access through 
a vertical right axillary mini-thoracotomy (VRAMT) in 2010. Given the convincing results the 
VRAMT access was stepwise expanded to more complex cardiac defects. In 2014 surgical 
correction of complete atrio-ventricular septal defects (CAVSD) through VRAMT was 
initiated, which has not been described in literature before [14]. 
 
This report analyzes the perioperative outcomes of VRAMT for the correction of a variety of 
congenital cardiac defects. Furthermore, the study includes an analysis of percutaneous 
femoral vein cannulation and of the extracorporeal circulation (ECC) performance in relation 
to body surface area. 
 










Patient selection and data collection  
A cardiosurgical database search (January 2012 until December 2018) was conducted and 
patients <16 years of age with the following preoperative diagnosis undergoing VRAMT were 
identified: atrial septal defect (ASD), ventricular septal defect (VSD), partial atrioventricular 
septal defects (PAVSD), complete atrioventricular septal defects (CAVSD), partial 
anomalous pulmonary venous connection (PAPVC), double chambered right ventricle 
(DCRV) and cor tri-atriatum. Patient with a concomitant diagnosis of patent ductus-arteriosus 
(PDA), unbalanced AVSD, severe atrioventricular valve regurgitation and left persistent caval 
vein were excluded. All surgical procedures were performed by the same surgeon (AK). An 
observational study design was used following the STROBE statement [15]. All data were 
gathered in a standardized database using the Research-Electronic-Data-Capture (REDCap) 
system. Patient characteristics, procedural data and outcomes are presented in Tables 1-3. 
 
Preoperative diagnosis were made by transthoracic echocardiography and for intraoperative 
assessment with transesophageal echocardiography (TEE). The peri- and postoperative 
diagnostics included clinical examination and trans-thoracic echocardiography. As for the 
follow up, data regarding clinical status, wound complications, thorax deformities, surgical 
result, and residual lesions were extracted from the electronic patient charts. All statistical 
calculations were performed using Stata 12 (StataCorp LLC, College Station, Texas, USA). 
Data are presented as mean with standard deviation (SD) or median with range [lowest 
value–highest value] depending on data distribution. The study was approved by the 
cantonal ethics committee.  
 
Patient selection for VRAMT 
For several years, VRAMT has been the standard approach for repair of secundum ASD, 
sinus venous defect, partial-anomalous-pulmonary-venous-return, partial atrioventricular 
septal defects. Given the growing institutional experience with this cosmetically appealing 
and less invasive approach, and its comparable results to the standard access the median 
sternotomy, our group extended its use, since 2012, to perimembranous VSD repair [14]. 
Furthermore since 2014 the VRAMT approach was used for correction of CAVSD with a 




The follow-up included ambulatory visits with physical examination and echocardiography by 








thereafter. All follow-up data were included in the analyses. For the purpose of this study, all 
echocardiographic data at discharge and the most recent follow-ups are included.  
 
Definition of major adverse cardiac and cerebrovascular events 
Major adverse cardiac and cerebrovascular events (MACCE) were defined as sudden 
cardiac death, myocardial infarction (MI), cardiac arrhythmias needing intervention with 
permanent pacemaker implantation, neurological complications, or renal failure requiring 
replacement therapy. Myocardial infarction was defined according to the Third Universal 
Definition of Myocardial Infarction by the European Society of Cardiology Guidelines as 
elevation of cardiac high-sensitive troponin (hs-cTnT) >10 x 99th percentile in patients 
with normal baseline hs-cTnT levels [16].  
Surgical technique  
Patients received general anesthesia with endotracheal intubation after induction with 
sevoflurane, sufentanil and rocuronium. Intraoperative monitoring followed American 
Society of Anesthesiologists standard monitoring including invasive arterial and central 
venous pressure, near-infrared spectroscopy and tranesophageal echocardiography. 
Additionally, a peripheral venous catheter sheath (Size: 4 Fr.) was inserted in the right 
femoral vein using ultrasound guidance if percutaneous venous cannulation was planned 
(Figure 1 A). The anterior, posterior axillary line and 4th intercostal space were outlined in 
supine position with arms in adduction and patients were placed in a left decubitus 
position. Following lateral positioning of the child the arm was elevated to expose the 
axillary region (Supplemental Video 1).  
 
A vertical incision of 4-5 cm parallel to the right anterior axillary fold was performed 
overlying the 4th or 5th-intercostal-space. The subcutaneous tissue was generously 
mobilized. The serratus anterior muscle overlying the 4th-intercostal-space was identified 
and the lateral border of the pectoral muscle slightly mobilized. Care was taken to avoid 
injury to the long thoracic nerve and artery lying posteriorly on the serratus anterior 
muscle. Thoracotomy was performed at the superior margin of the 5th-rib in the 4th 
intercostal space. A retractor (Fehling Instruments, Karlstein, Germany) was selected 
according to patient weight: 3-7 kg: V-CUT Titanium MSX-1, 7-15 kg: MSX-2) (Figure 1 
A). The pericardium was opened 1.5 - 2 cm anterior to the phrenic nerve. Stay sutures 
were placed along the margins of the pericardium and fixed to the surrounding drapes to 
retain the lungs (Figure 1 B). 
 
Extracorporeal circulation (ECC) was established following cannulation of the ascending 









l/min/m2 (BSA) at normothermia (36° Celsius) was defined as optimal ECC flow [17]. The 
inferior vena cava was either cannulated directly or in patients >5kg a percutaneous 
venous cannula (BIO-MEDICUS, Medtronic: Pediatric-Venous-Cannulae Sizes 8-14Fr. / 
Bio-Medicus NextGen Femoral Venous Cannulae 15-25 Fr) was inserted into the femoral 
vein using Seldinger technique (Supplemental Video 1).  
For interventions with aortic cross-clamping a left ventricular vent and ascending aortic 
root vent were placed. ECC was conducted in mild hypothermia. CO2 insufflations into the 
thoracic cavity ware routinely applied. The correction of ASD and PAPVC were performed 
in induced ventricular fibrillation for the majority of cases.  
For all other procedures, the aorta was cross-clamped and antegrade cardioplegia was 
administered by using a low-dose (1.5 ml/kg), single-shot crystalloid solution (Cardio-
plexol™, Swiss Cardio Technologies AG, Switzerland) [18]. The surgical repair of the 
congenital cardiac defects through VRAMT followed standard techniques (Video 1).  
 
Deairing was performed via a left ventricular vent and the aortic root vent. During 
rewarming epicardial electrodes for temporary pacing were placed to the right atrium and 
ventricle. Following central decannulation and protamine administration, the peripheral 
percutaneous venous cannulas was removed, and hemostasis was achieved by manual 
compression for at least 10 minutes. The pericardium was closed except for a distal 
opening (1-2 cm) allowing drainage of pericardial fluid into the right pleural space. A 
subpleural paravertebral catheter was placed covering two segments each cranial and 
caudal to the VRAMT interspace for postoperative pain management. A standard solution 
of bupivacaine 0.125% was continuously infused for up to 72 hours. Two chest drains 





Patient characteristics and preoperative data  
A total of 110 patients (55 female) were included in the study (Table 1). Overall age was at a 
median of 2.3 (02-16) years and a median weight of 11 kg (3-47). Median body surface area 
of all patients was at a median of 0.5 (0.2-1.5) m2. Gender distribution was equal with 55 
females (50%). Non-cardiac diagnosis included genetic disorders (n=18, of which 11 with 
Trisomy 21), neurological disorders (n=3), metabolic disorders (n=8), urogenital disorders 










Intraoperative Data and Assessment 
In all patients the correction could be performed through the right axillary minimal invasive 
access, there was no need for conversion to a different approach. Intraoperative data and 
cardiopulmonary bypass characteristics are listed in Table 2. Concomitant procedures in the 
VSD group included ASD closure with direct suture (n=15), tricuspid valve reconstruction 
(n=24), and PFO closure (n=1). One patient with PAVSD underwent right atrio-ventricular 
valve reconstruction. 
 
Percutaneous venous cannulation 
Thirty-eight patients (35%) underwent percutaneous-femoral-venous cannulation. In one 
early case femoral venous cannulation was intended but overall drainage was too low, and a 
switch to central cannulation was performed. Cannula sizes related to the Body Surface Area 
of the patients are shown in Figure 3. The optimal calculated and achieved ECCflow rates at 
normothermia (36°Celcius) for patients with percutaneous-femoral-venous cannulation 
(n=38) of the inferior vena cava are plotted in Figure 4. The optimal calculated ECC flow at 
normothermia was achieved when the percutaneous-transfemoral-venous cannula size was 
equal to or smaller than SVC venous cannula size. Oversizing of the percutaneous-femoral-
venous cannula lead to decreased ECC flow (Figure 4. Arrows). 
 
Postoperative Assessment 
Postoperative data are presented in Table 3. Starting in 2016, fast-track management with 
on-table extubation was performed whenever possible 
 
There were no major adverse cardiac and cerebrovascular events (MACCE). Postoperative 
complications included pneumonia (n=2) and the need of permanent pacemaker implantation 
for complete heart block in a patient with CAVSD (n=1). Overall, the median hospital length 
of stay was at seven (4-31) days. There was no case of 30-day mortality. 
 
For patients with percutaneous-femoral-venous cannulation (n= 38, 35%), thrombosis at the 
cannulation site in the right femoral vein was detected in five (13.5%) cases (Figure 3) 
postoperatively by ultrasound. In patients with a BSA <0.3m2 venous thrombosis at the 
cannulation site was most common with the use of a 12 French percutaneous-venous 
cannula was used (Figure 3). 
 
Anticoagulation therapy was initiated with unfractionated heparin. Heparin infusion rate was 
maintained according to anti-Xa activity of 0.3 - 0.5 U/mL. There were no cases of persistent 









ultrasound before discharge. There was no case of bleeding, nor was any surgical 
intervention at the peripheral cannulation site needed. 
 
Follow up 
Follow-up is complete with a median follow up time of 14.4 (0.8 – 47.19) months, 
respectively. Follow-up data include the results of a transthoracic echocardiography at 
discharge from the hospital and the findings of the last clinical checkup at ambulatory patient 
visit. Ambulatory follow up visits included clinical examinations as well as echocardiography. 
There have been no cases of late mortality. The latest echocardiographic follow-up data are 
presented in Supplemental Table 1. 
 
In the follow-up period, surgical re-intervention was necessary in one patient with CAVSD. 
The patient underwent reoperation due to a new severe left atrio-ventricular valve 
insufficiency that had not been observed at the end of the index procedure. The reoperation 
was performed through the previous VRAMT access. The dysfunction was caused by a 
suture detachment of the cleft closure. The patient was reoperated by re-reconstruction of 




The ongoing general strategy for less invasive procedures has increased the quest for 
minimally invasive accesses, also in the field of corrective heart surgery. Several publications 
have shown that less invasive thoracic incisions can be safely applied for the correction of 
simple congenital heart defects in pediatric patients [3,5,13,19]. The right axillary mini-
thoracotomy was developed to improve the cosmetic results while allowing equal surgical 
outcome for corrective heart surgery (e.g. ASD) [3,14].  
 
Following the original institutional experience with vertical right axillary mini thoracotomy for 
the correction of simple congenital heart defects, the technique of VRAMT was transferred to 
more complex cardiac malformations. Nowadays VRAMT has become the standard 
procedure for the correction of atrial and ventricular septal defects, partial and complete 
atrio-ventricular septal defects (Rastelli type A), partial anomalous pulmonary venous return, 
double chambered right ventricle, and cor triatriatum. 
 
As far as aortic cross-clamp times, cardiopulmonary bypass time and operation time are 
concerned, VRAMT procedures are comparable to standard median sternotomy, indicating 
an adequate exposure and access to the required anatomical structures [14]. Furthermore, 









correction itself. These findings confirm previously reported advantages and results by other 
groups [4,5,13,20,21].  
 
As described in our series, 50% of the patients are female; this emphasizes the need for a 
surgical access that spares developing breast tissue. Furthermore, no later impairment of 
breast development was observed, neither did any of the patients suffer from thorax 
deformity during growth.  
 
Optimal surgical exposure is crucial for the assessment and correction of cardiac 
malformations while cardiopulmonary bypass installations take up space in the already 
minimized surgical operative field. The cannulation of femoral vessels reduces this problem 
but may be followed by thrombotic complications when small vessels are considered. 
Previous studies have described various complications after peripheral vessel cannulation, 
especially for arterial vessels in neonates and small children, thus the indication for this 
method has to be carefully evaluated in every patient [13,20].  
 
Percutaneous peripheral cannulation of the femoral vein has been performed in all patients 
since 2016 for VRAMT, while the aortic cannula and SVC cannula are placed centrally. The  
IVC drainage through a peripheral cannulation improves the surgical access and increases 
the view to the more caudal structures, for instance in the correction for CAVSD. 
Furthermore, potential complications and compromises due to cannulation of rather small 
femoral arteries with cannulas, large enough to provide adequate ECC perfusion in mild 
hypothermic bypass, can be avoided. Femoral artery cannulation has led to access site 
complications in other studies and should therefore be performed only with limited indication 
and meticulous technique. 
 
Nevertheless, we recorded five cases of early thrombosis (<24h) at the cannulation site in 
the right femoral vein in the initial period after starting percutaneous femoral vein 
cannulation. Retrospectively, it appears that this complication was mostly due to an 
oversizing of the cannula size. Since we routinely adopted postoperative prophylactic 
antithrombotic therapy by unfractionated heparin treatment, these complications have not 
reoccurred.   
 
Furthermore, we analyzed the percutaneous venous cannula sizes in relation to the body 
surface area of the patients. Purpose for this analysis is based on the situation that the 
percutaneous femoral cannulas have a different design to the standard cannulas. In contrast, 









drainage at smaller diameters. The optimal calculated ECC flow at normothermia was 
achieved when the percutaneous-transfemoral-venous cannula size was equal to or smaller 
than SVC venous cannula size. Oversizing of the percutaneous-femoral-venous cannula lead 
to decreased ECC flow with suction events. We could demonstrate that in patients with a 
BSA of <0.3m2 a 8 Fr. percutaneous venous cannula provides sufficient hemodynamic 
performance.  
 
The only reoperation was needed in one patient who received correction of CAVSD due to a 
dehiscence of the cleft suture. The reoperation of the patient could be performed through the 
previous incision site and re-reconstruction of the valve 42 days after the initial correction. 
We believe that the routine closure of the pericardium is advantageous in regard to potential 
re-interventions. The postoperative course was uneventful. 
Conclusion 
 
This study confirms previous reports that described VRAMT as a feasible and efficient 
approach for surgical repair of congenital heart defects with cosmetically favorable results 
and with comparable surgical results to median sternotomy. Cardiopulmonary bypass can be 
performed without peripheral arterial cannulation while percutaneous femoral vein 
cannulation provides sufficient ECC flow. The latter can be safely applied even in smaller 




The patient collective is relatively small, especially for less frequent malformations. Since 
VRAMT is the standard approach for many heart defects and the overall case number is 
small, there was no control group. However, the fact that all cases were performed by the 
same surgeon and surgical team provides an adequate consistency of technique and quality 
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Diagnosis n Age (years) Weight (kg) Height (cm) Body Surface Area (m 2) 
ASD II° 35 (32%) 5.58 (0.5-16) 18.5 (5-47) 110 (64-155) 0.7 (0.3-1.4) 
VSD 44 (40%) 0.55 (0.2-15) 7.1 (3-39) 69 (54-154) 0.4 (0.2-1.3) 
CAVSD 12 (11%) 0.51 (0.2-1.3) 5.8 (4.3-9.1) 67 (50-76) 0.3 (0.2-0.4) 
PAVSD 7 (6%) 2.9 (0.75-6) 10 (9-18) 91 (73-120) 0.5 (0.4-0.8) 
PAPVC 9 (8%) 4.9 (2-12) 17 (9-47) 107 (86-159) 0.7 (0.5-1.5) 
DCRV 1 (1%) 1.00 12.00 79.00 0.49 
Cor Tria-
triatum 2 (2%) 4.9 (2-7) 13 (9-17) 97 (8-114) 0.6 (0.4-0.7) 
Total 110 2.3 (0.2-16) 11 (3-47) 85 (50-159) 0.5 (0 .2-1.5) 
 
Table 1:  Patient demographic data. Data are n (%) or median (min-max), unless otherwise 
indicated. ASD II°: secondary atrio-septal defects, CAVSD: complete atrio-ventricular septal 
defects, DCRV: double chambered right ventricle PAVSD: partial atrio-ventricular septal 













Diagnosis n Surgical time (min) ECC time (min) 
X-clamp time 
(min) BH (n) PVC (n) 
ASD II° 35 (32%) 125 (83-210) 42 (24-115) 14 (9-20) 32  17 
VSD 44 (40%) 159 (120-238) 76 (54-140) 41 (21-67) 0 15 
CAVSD 12 (11%) 189 (110-212) 106 (66-139) 64 (37-73) 0 2 
PAVSD 7 (6%) 155 (113-220) 75 (46-167) 42 (21-95) 0 1 
PAPVC 9 (8%) 150 (70-180) 59 (27-80) 39 (38-41) 7 3 
DCRV 1 (1%) 110.00 56.00 28.00 0 0 
Cor Tria-
triatum 2 (2%) 155 (150-160) 86 (85-87) 42 (39-46) 0 0 
Total 110 150 (70-238) 66 (24-167) 41 (9-95) 39 38 
 
Table 2:  Intraoperative Data. Data are n (%) or median (min-max), unless otherwise 
indicated. ASD II°: secondary atrio-septal defects, BH: Beating heart, Cross-lamp time of the 
aorta, CAVSD: complete atrio-ventricular septal defects, DCRV: double chambered right 
ventricle, ECC: Extracorporeal circulation, PAVSD: partial atrio-ventricular septal defects, 
PAPVC: partial abnormal pulmonary venous connection, PVC: Peripheral inferior vena cava 











Table 3:  Postoperative data. Data are n (%) or median (min-max), unless otherwise 
indicated. ASD II°: secondary atrio-septal defects, CAVSD: complete atrio-ventricular septal 
defects, DCRV: double chambered right ventricle ICU: intensive care unit OR: operation 
room, PAVSD: partial atrio-ventricular septal defects, PAPVC: partial abnormal pulmonary 
venous connection, VSD: ventricular-septal defects. 
 
  
Diagnosis Total (n) Extubation in OR (n) 
Time on ventilator 
(h) 
ICU length of stay 
(h) 
Hospital length of 
stay (d) 
ASD II° 35 (32%) 18 4 (2-24) 48 (20-110) 6 (4-18) 
VSD 44 (40%) 12 20 (3-96) 72 (3-259) 8 (5-21) 
CAVSD 12 (11%) 0 32.5 (2-12) 123 (45-288) 12 (8-31) 
PAVSD 7 (6%) 2 6 (3-20) 45 (23-70) 6 (4-7) 
PAPVC 9 (8%) 5 4 (2-11) 50 (24-147) 5 (4-9) 
DCRV 1 (1%) 0 8.00 49.00 7.00 
Cor Triatriatum 2 (2%) 1 10 (3-18) 21 (18-24) 5.5 (5-6) 











Figure 1:  A. Placement of patients in a left decubitus position with surgical access site and 
peripheral-venous-catheter-sheath (PVC) in right femoral vein. B. Visualization of the right 
atrium (RA) and superior vena cava (SVC).  
 
Figure 2:  Direct aortic cannulation (AoC), superior vena cava (SVC) and placement of aortic 
root vent (ARV). The inferior vena cava was cannulated using percutaneous-venous 
cannulation (PVC) technique. 
 
Figure 3:  Femoral venous cannula sizes in relation to Body-Surface-Area. Patients with 
postoperative thrombosis are marked in red. Fr: French scale system 
 
Figure 4:  Venous Cannula Sizes (FR) in relation to Body Surface area and maximal 
achieved perfusion flow (l/min) versus, optimal calculated flow for extracorporeal circulation 
circuit at normothermia. Arrows show decreased ECC flow. Fem Cannula: Femoral Cannula, 
FR: French, SVC: superior vena cava 
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